FTSE100

Smith+Nephew introduces pioneering new technologies for its JOURNEY™ II total knee arthroplasty portfolio

Retrieved on: 
Wednesday, September 1, 2021
TKA, PS, Congress, Instagram, Sports medicine, Wake Forest Baptist Medical Center, Gait, PCL, Neacoryphus bicrucis, FTSE100, AAOS, Unlimited, Patent, Associate, U.S. Securities and Exchange Commission, Poster, Femur, The Chartered Institute of Ergonomics and Human Factors, United States patent law, Forward-looking statement, Veni, vidi, vici, Patient, Technology, MD, Twitter, Group, Phrase, Motion, Failure, LinkedIn, United States Patent and Trademark Office, Annual report, ENT, Longevity, LSE, Form 20-F, NYSE, SYNC, Posterior cruciate ligament, Comparison, Smith & Nephew, SNN, Medical device, Pharmaceutical industry

The design goal of the entire JOURNEY II family is to recreate the normal shapes, position and motion of the healthy knee.

Key Points: 
  • The design goal of the entire JOURNEY II family is to recreate the normal shapes, position and motion of the healthy knee.
  • "I am excited about the addition of the Medial Dished insert to the JOURNEY II CR Total Knee System," said Dr. Kevin Fricka, Orthopaedic Adult Hip and Knee Reconstruction at Anderson Orthopaedic Clinic.
  • "This insert will allow me the flexibility I need to achieve excellent knee kinematics in both cruciate sacrificing and cruciate retaining total knee replacement procedures."
  • Patel AR, Delhougne G. Hospital related clinical and economical outcomes of two premium knee systems in total knee arthroplasty (TKA) patients.

Smith+Nephew launches new total ankle and total shoulder replacement technologies; showcases recently acquired Extremity Orthopaedics portfolio at AAOS

Retrieved on: 
Tuesday, August 31, 2021
Titan, Instagram, Sports medicine, Efficiency, FTSE100, AAOS, Foot, Unlimited, Solution, Patent, Hand, Wrist, U.S. Securities and Exchange Commission, Fracture, Merck KGaA v. Integra Lifesciences I, Ltd., Annual general meeting, Doctor of Philosophy, United States patent law, Forward-looking statement, Integra, Deformity, Technology, Ankle, Twitter, Group, Surgeon, Phrase, Elbow, OR, Failure, LinkedIn, Shoulder, Printing, View, United States Patent and Trademark Office, Anatomy, MS, Annual report, ENT, Longevity, LSE, PSI, American Academy, Form 20-F, CA, NYSE, Multimedia, Patient, Smith & Nephew, OR1, Talus, SNN, Medical imaging, Dentistry, Pharmaceutical industry

Smith+Nephew is also announcing the full market release of two key products in the total ankle and total shoulder replacement segments - the CADENCE Total Ankle Flat Cut Talar Dome System and ATLASplan Shoulder 3D Planning and patient-specific instrument (PSI) System.

Key Points: 
  • Smith+Nephew is also announcing the full market release of two key products in the total ankle and total shoulder replacement segments - the CADENCE Total Ankle Flat Cut Talar Dome System and ATLASplan Shoulder 3D Planning and patient-specific instrument (PSI) System.
  • The CADENCE Total Ankle Flat Cut Talar Dome (System) expands Smith+Nephew's continuum of care for patients with end stage ankle arthritis.
  • It incorporates features designed to help reduce potential clinical complications, accommodate various patient anatomies, and address common challenges with ankle arthroplasty.
  • To learn more about our new Extremities portfolio, please stop by the Smith+Nephew booth (#1735) during AAOS 2021.

Smith+Nephew launches new total ankle and total shoulder replacement technologies; showcases recently acquired Extremity Orthopaedics portfolio at AAOS

Retrieved on: 
Tuesday, August 31, 2021
Titan, Instagram, Sports medicine, Efficiency, FTSE100, AAOS, Foot, Unlimited, Solution, Patent, Hand, Wrist, U.S. Securities and Exchange Commission, Fracture, Merck KGaA v. Integra Lifesciences I, Ltd., Annual general meeting, Doctor of Philosophy, United States patent law, Forward-looking statement, Integra, Deformity, Technology, Ankle, Twitter, Group, Surgeon, Phrase, Elbow, OR, Failure, LinkedIn, Shoulder, Printing, United States Patent and Trademark Office, Anatomy, MS, Annual report, ENT, Longevity, LSE, PSI, American Academy, Form 20-F, CA, NYSE, Patient, Smith & Nephew, OR1, Talus, SNN, Medical imaging, Dentistry

Smith+Nephew is also announcing the full market release of two key products in the total ankle and total shoulder replacement segments - the CADENCE Total Ankle Flat Cut Talar Dome System and ATLASplan Shoulder 3D Planning and patient-specific instrument (PSI) System.

Key Points: 
  • Smith+Nephew is also announcing the full market release of two key products in the total ankle and total shoulder replacement segments - the CADENCE Total Ankle Flat Cut Talar Dome System and ATLASplan Shoulder 3D Planning and patient-specific instrument (PSI) System.
  • The CADENCE Total Ankle Flat Cut Talar Dome (System) expands Smith+Nephew's continuum of care for patients with end stage ankle arthritis.
  • It incorporates features designed to help reduce potential clinical complications, accommodate various patient anatomies, and address common challenges with ankle arthroplasty.
  • To learn more about our new Extremities portfolio, please stop by the Smith+Nephew booth (#1735) during AAOS 2021.

Smith+Nephew to feature new Sports Medicine technology for joint repair and connected arthroscopic tower during AAOS 2021 Annual Meeting

Retrieved on: 
Monday, August 30, 2021
Arthroscopy, TKA, THA, Sports medicine, Instagram, Bleeding, FTSE100, Meniscus, AAOS, Sheep, Infection, Pulitzer Prize for International Reporting, Cannula, Belle Meade, Tennessee, Unlimited, TTD, MRI, Laparoscopy, Patent, U.S. Securities and Exchange Commission, DV, Biopsy, Annual general meeting, The Journal of Bone and Joint Surgery, United States patent law, Forward-looking statement, TJA, WQ, Technology, Arthroscopic lavage, Twitter, Group, Surgeon, Tendon, LENS, Medicine, Ligament, Phrase, Failure, LinkedIn, Direct-view bistable storage tube, Memorandum, United States Patent and Trademark Office, Anatomy, Muscle, Annual report, Growth, ENT, Longevity, LSE, American Academy, Form 20-F, CA, Clinical, Deborah Delanoy, NYSE, Hemostasis, Parks P-1, Temperature, Smith & Nephew, SNN, Dentistry, Silviculture, Medical device, Silk

Recent advancements to the connected tower include a new pump and 4K optimized scopes.

Key Points: 
  • Recent advancements to the connected tower include a new pump and 4K optimized scopes.
  • Such technology has shown to significantly reduce total blood loss*11 as well as significantly shortening procedure time.
  • ***15,18 A new study shows how REGENETEN is setting a new standard of recovery for partial-thickness rotator cuff tears.
  • To learn more about these ground-breaking Sports Medicine innovations, please stop by the Smith+Nephew booth (#1735) during AAOS 2021.

DCC Technology Forms Exertis North America Business Unit

Retrieved on: 
Thursday, August 19, 2021
Professional Services, Technology, Other Professional Services, Other Technology, Audio, Video, Software, People, Health care, Technology, Growth, MI, LPG, Acquisition, Certification Commission for Healthcare Information Technology, Society, CE, U.S. Music Corporation, JB, Marketing, DCC, CFO, FTSE100, AV, Multimedia, Stampede, Solution, CEO, CT, FTSE, Professional audio, Management

DCC Technology, an international technology value added distribution specialist with market leading businesses in 20 countries including the US, Canada, Europe, and the Middle East, today announced the formation of a new business unit, Exertis North America, to manage the operations of its recent acquisitions Jam Industries and Stampede.

Key Points: 
  • DCC Technology, an international technology value added distribution specialist with market leading businesses in 20 countries including the US, Canada, Europe, and the Middle East, today announced the formation of a new business unit, Exertis North America, to manage the operations of its recent acquisitions Jam Industries and Stampede.
  • View the full release here: https://www.businesswire.com/news/home/20210819005199/en/
    Marty Szpiro, President and CEO of Jam Industries (Photo: Business Wire)
    According to Tim Griffin, Managing Director of DCC Technology, Marty Szpiro, the long-time President and CEO of Jam Industries, is stepping up to serve as President & CEO of Exertis North America.
  • DCC Technologys has established leadership positions in selected value-added distribution specialisms in North America, Griffin said today.
  • Clive Fitzharris, Managing Director of Exertis International, added that, We are delighted with the growth and development of our Exertis branded business in North America.

DS Smith exploring plans for seaweed paper and packaging

Retrieved on: 
Wednesday, August 18, 2021
Industry, Circular economy, Research, Plastic, Paper, Heart, FTSE100, Natural Resources, Biotechnology, Wood, DS Smith, Environment, Seaweed, Tissue paper, Aquaculture, Recycling

LONDON, Aug. 18, 2021 /PRNewswire/ -- DS Smith, the FTSE100 packaging company, is exploring how seaweed fibres can be used as a raw material in paper and packaging products amid increasing demand for sustainable goods from customers and consumers alike.

Key Points: 
  • LONDON, Aug. 18, 2021 /PRNewswire/ -- DS Smith, the FTSE100 packaging company, is exploring how seaweed fibres can be used as a raw material in paper and packaging products amid increasing demand for sustainable goods from customers and consumers alike.
  • In an industry first, the move could see DS Smith use seaweed across its packaging network as an alternative fibre source to wood.
  • DS Smith is talking to a number of biotechnology companies to explore the use of seaweed fibres in a range of packaging products such as cartons, paper wraps and cardboard trays.
  • By 2023, DS Smith will manufacture 100% reusable or recyclable packaging and its aim is that by 2030, all of its packaging will be recycled or reused.

Smith+Nephew expands its leading WEREWOLF™ Technology into total joint arthroplasty with launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand

Retrieved on: 
Tuesday, August 17, 2021
TKA, THA, Annual report, Twitter, ENT, Instagram, Longevity, Technology, U.S. Securities and Exchange Commission, Group, Surgeon, LSE, Bleeding, MAX, PB, Phrase, Form 20-F, Patent, SVP, Ear, Nose, Abraham Delanoy, United States patent law, FTSE100, Forward-looking statement, NYSE, TJA, Multimedia, Hemostasis, Infection, Temperature, Belle Meade, Tennessee, Failure, Patient, Unlimited, Schaffner, Smith & Nephew, LinkedIn, FDA, GM, SNN, View, United States Patent and Trademark Office, Pharmaceutical industry

LONDON, Aug. 17, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand, bringing its leading radio-frequency technology to orthopaedic reconstruction surgeons.

Key Points: 
  • LONDON, Aug. 17, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand, bringing its leading radio-frequency technology to orthopaedic reconstruction surgeons.
  • Using low temperature thermal energy, the FASTSEAL 6.0 Hemostasis Wand delivers hemostatic sealing during open orthopaedic procedures such as total joint arthroplasty (TJA) this technology has shown to significantly reduce total blood loss*1 as well as significantly shortening procedure time.
  • "The FASTSEAL 6.0 Hemostasis Wand excels in its delivery of hemostasis.
  • The launch of the FASTSEAL 6.0 Wand expands the WEREWOLF platform utilising Smith+Nephew's leading radio-frequency technology.